XML 41 R30.htm IDEA: XBRL DOCUMENT
v3.21.2

Equity Investees (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2021
Equity Method Investments and Joint Ventures [Abstract] |
Schedule of Consolidated Financial Statements Related to Equity Investees | The following table presents information included in our Unaudited Condensed Consolidated Financial Statements related to our equity investees:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Genesis’ share of operating earnings | $ | 14,174 |  |  | $ | 18,312 |  |  | $ | 56,801 |  |  | $ | 52,834 |
Amortization of excess purchase price | (3,873) |  |  | (3,873) |  |  | (11,618) |  |  | (11,618) |
Net equity in earnings | $ | 10,301 |  |  | $ | 14,439 |  |  | $ | 45,183 |  |  | $ | 41,216 |
Distributions received (1) | $ | 17,443 |  |  | $ | 16,757 |  |  | $ | 68,873 |  |  | $ | 55,716 |
(1) Includes distributions attributable to the period and received during or promptly following such period.
Schedule of Balance Sheet Information for Equity Investees | The following tables present the unaudited balance sheet and income statement information (on a 100% basis) for Poseidon Oil Pipeline Company, L.L.C. ("Poseidon") (which is our most significant equity investment):
| September 30, 2021 |  | December 31, 2020
BALANCE SHEET DATA: |  |  |
Assets |  |  |
Current assets | $ | 22,890 |  |  | $ | 30,465 |
Fixed assets, net | 164,096 |  |  | 171,732 |
Other assets | 5,762 |  |  | 4,673 |
Total assets | $ | 192,748 |  |  | $ | 206,870 |
Liabilities and equity |  |  |
Current liabilities | $ | 12,001 |  |  | $ | 9,958 |
Other liabilities | 237,507 |  |  | 237,595 |
Equity (Deficit) | (56,760) |  |  | (40,683) |
Total liabilities and equity | $ | 192,748 |  |  | $ | 206,870 |
Schedule Of Operations For Equity Investees |
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
INCOME STATEMENT DATA: |  |  |  |  |  |  |
Revenues | $ | 27,262 |  |  | $ | 35,351 |  |  | $ | 103,432 |  |  | $ | 98,662 |
Operating income | $ | 18,762 |  |  | $ | 27,002 |  |  | $ | 75,559 |  |  | $ | 72,530 |
Net income | $ | 17,718 |  |  | $ | 25,831 |  |  | $ | 72,473 |  |  | $ | 68,050 |

X
- Definition Represents the share of equity investment earnings included in the consolidated statement of operations less the amortization of the excess purchase. The table also includes distributions received from equity method investments. + References No definition available. + Details
Name: | gel_ConsolidatedFinancialStatementsRelatedToEquityInvesteesTableTextBlock
Namespace Prefix: | gel_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents in the aggregate the total asset and liability amounts of equity method investments. + References No definition available. + Details
Name: | gel_ScheduleOfBalanceSheetInformationForEquityInvesteesTableTextBlock
Namespace Prefix: | gel_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents in the aggregate total revenues, operating income and net income of equity method investments. + References No definition available. + Details
Name: | gel_ScheduleOfOperationsForEquityInvesteesTableTextBlock
Namespace Prefix: | gel_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration